TrialCNS neuroscience & therapeutics2016

Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects.

John J Sramek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.